Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAFE-HEaRt: A Pilot Study Assessing the Cardiac SAFEty of HER2 Targeted Therapy in Patients With HER2 Positive Breast Cancer and Reduced Left Ventricular Function

NCT01904903 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT01904903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01904903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAFE-HEaRt: A Pilot Study Assessing the Cardiac SAFEty of HER2 Targeted Therapy in Patients With HER2 Positive Breast Cancer and Reduced Left Ventricular Function
Lead sponsor
Medstar Health Research Institute
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
June 30, 2020
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

her2 positive breast cancer, left ventricular function systolic dysfunction